Strategic Initiatives
Gilead Sciences' Toward Health Equity Oncology Grant funds innovative projects improving cancer care access and health equity for underserved populations in the U.S., Australia, Canada, and Europe.
Funder: Gilead Sciences
Due Dates: Rolling (Applications accepted throughout the year)
Funding Amounts: Varies by program and project; typical grants support innovative, high-impact projects addressing health inequities.
Summary: Supports organizations advancing health equity in oncology and other therapeutic areas through global partnerships, education, and expanded care access.
Key Information: Focus on projects in the U.S., Australia, Canada, and Europe; emphasis on underserved populations and health inequities in cancer.
Description
Gilead Sciences' Strategic Initiatives provide grant funding to organizations addressing critical health challenges, including cancer, HIV, viral hepatitis, and health inequities. The Toward Health Equity Oncology Grant®—part of these initiatives—specifically aims to advance health equity for people impacted by cancer in the U.S., Australia, Canada, and Europe. The program supports projects that increase access to care, foster community engagement, promote education, and target populations disproportionately affected by disease, including Black women impacted by triple-negative breast cancer (TNBC). Grants are designed to strengthen community capacity and promote meaningful, sustainable change beyond medicine.
